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Abstract 
Introduction 
The aim of the study is to review the bothersome lower urinary tract 
symptoms, risk factors and associated functional urinary abnormalities in 
women reporting adult onset secondary nocturnal enuresis (SNE), to help 
understand the pathophysiology of SNE. 
Methods 
12795 women (age > 18) attending a single tertiary referral centre underwent 
a comprehensive standardized evaluation including urodynamic testing in 
accordance with the recommendations of the International Continence 
Society. Records of all patients reporting bedwetting whilst asleep were 
evaluated under various categories. Multiple logistic regression was fitted to 
identify statistically significant risk factors and urodynamic findings associated 
with SNE. 
Results 
The prevalence of SNE in women undergoing urodynamic testing for 
bothersome LUTS was 14.4% (1838). High BMI (OR= 1.47, p< 0.001), 
cigarette smoking (OR= 2, p< 0.001), antidepressant usage (OR= 1.8, p< 
0.001), neurological conditions (OR= 2.12, p< 0.001) and previous 
hysterectomy (OR= 1.19, p= 0.03) were significantly associated with SNE. 
Women with SNE significantly complained of overactive bladder symptoms 
(OR= 1.65, p< 0.001) and slightly higher mean nocturia episodes (OR= 1.38, 
p< 0.0001). Low maximum urethral closure pressure (MUCP) (OR= 1.34, 
p<0.0001) and urodynamically demonstrable detrusor overactivity 
incontinence (DOI) (OR= 1.75, p<0.0001) were significantly associated with 
SNE. There was no significant association with the symptom of stress urinary 
incontinence (SUI) (p= 0.264), urodynamically demonstrable stress 
incontinence (p= 0.454) or detrusor overactivity (p= 0.231).  
Conclusion 
Adult SNE is rarely monosymptomatic and patients usually present with OAB 
symptoms. SNE is associated with high BMI, cigarette smoking, 
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antidepressant use and neurological conditions. DOI and a low MUCP seems 
to be the main pathophysiological mechanisms associated with SNE.  
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Introduction 
Nocturnal enuresis (NE) is a highly bothersome lower urinary tract symptom 
of involuntary loss of urine occurring at sleep (Haylen et al. 2010). NE can be 
considered as primary (life-long) or secondary (arising after a period without 
bedwetting of at least one year). It can also be monosymptomatic or 
polysymptomatic (arising in conjunction with other symptoms). NE is common 
in children and at 5 years of age up to 25% of children wet the bed (Wan & 
Greenfield 1997). With each year of maturity the percentage of bed wetting 
declines by 15 percent, with 8 percent of twelve year old boys and 4 percent 
of 12 year old girls are enuretic, and this number at adolescent is between 1 
and 3% (Thiedke 2003). Longitudinal follow up studies have suggested that 
3% of adults over 20 years of age remain enuretic from childhood and are at 
risk of remaining enuretic for the rest of their lives (Moilanen et al. 1998; 
Forsythe & Redmond 1974). However, NE may develop as a new symptom in 
adults after achieving control for a reasonable period of time (Adult onset 
secondary nocturnal enuresis). Adult onset secondary nocturnal enuresis is 
the focus of investigation in this paper and will henceforth be referred to as 
SNE. The prevalence of SNE in women, especially with LUTS is not known. A 
large epidemiological survey from the Netherlands suggested an overall 
prevalence of NE at 0.5% in non-institutionalized adults aged between 18 to 
64 years, with no difference in age groups or sexes (Hirasing et al. 2009).  
Various mechanisms including deficient vasopressin release, sleep disorders, 
psychosocial problems, genetic factors and anatomical bladder problems 
have been implicated in the pathophysiology of NE (Thiedke 2003; Hirasing et 
al. 2009; Yeung 2003; Wolfish 2001; Umlauf & Chasens 2003). A reduction in 
the bladder capacity has been suggested by some studies (C K Yeung et al. 
2002), whilst this is not shown as a significant finding in other studies 
(Nørgaard & Djurhuus 1993). Detrusor overactivity (bladder instability) has 
also been implicated in the pathophysiology of NE (C K Yeung et al. 2002; 
Warwick & Whiteside 1979). NE in men has been suggested as a sign of a 
high pressure chronic urinary retention due to urethral outflow resistance, with 
a recommendation for investigations and treatment (SAKAMOTO & BLAIVAS 
2001; Abeygunasekera & Goonesinghe 2013). Even though urodynamic 
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investigations have been used in the assessment of adults with NE with or 
without other lower urinary tract symptoms, NE is still poorly understood, 
making management difficult and challenging. 
 
This study is a review of findings in all women (>18 years of age) reporting 
nocturnal enuresis when presenting for urodynamic testing for various lower 
urinary tract symptoms. The study attempts to characterise specific risk 
factors and urodynamic findings to further our understanding of this 
bothersome problem in adults. The aim is to draw conclusions to recommend 
further research and help manage women with this distressing condition.  
 
Methodology: 
The study was registered with the Research and Innovation department, 
Southmead Hospital, Bristol. Ethical approval was also obtained from the 
regional research ethics committee. All patients were seen in the Department 
of Urodynamics (Bristol Urological Institute) at Southmead Hospital, Bristol. 
Patients were referred from local, regional and national centres for 
urodynamic assessment. All patients were sent an information leaflet 
regarding the urodynamic procedure along with their appointment letter. A 
team of doctors and specialist urodynamic nurses saw the patients. A verbal 
consent was obtained prior to performing the test. A complete history and a 
pelvic examination were done in all patients. A urine analysis was carried out 
to rule out any infections in all the patients. Invasive and non-invasive 
urodynamic tests were done in all the patients according to the 
recommendations of the International Continence Society (ICS). Frequency 
volume charts of all the patients who filled them out were analyzed, but only 
mean daytime frequency and nocturia episodes were entered on to the 
database. All the patients reporting adult onset bedwetting (SNE) were 
included in the study. Patients with primary nocturnal enuresis (since 
childhood), with no period of remission, were excluded from the study. 
Patients aged less than 18 years were also excluded from this study. Data 
including history and urodynamic findings were kept on a database 
maintained by the North Bristol NHS trust, Bristol. All the trust standard 
operating procedures and policies were followed in the collection and analysis 
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of the data for this study. Data was analyzed as a whole group and also 
considered under various associated conditions. NE was considered under 
primary or secondary types. Patients with primary NE were excluded from 
analysis. NE was also considered in patients with or without overactive 
bladder symptoms. NE was also considered in patients smoking cigarettes, 
using antidepressants and associated neurological conditions. 
Data from the urodynamic database was anonymized and cleaned for clarity, 
and then analyzed using SPSS (IBM SPSS Statistics for Windows, Version 
21.0. Armonk, NY: IBM Corp [DGE1] ). Student’s t-test was used for testing 
differences in the mean between two continuous variables, while a Chi-square 
test was used for testing associations between categorical variables. A 
multivariate multiple logistic regression analysis was done with all the 
covariates in the model to evaluate the risk factors and urodynamic findings 
associated with SNE. Unless specified otherwise, all tests were made at a 5% 
level of significance. Whenever appropriate, p-values, Odds ratios and 95% 
confidence intervals were computed and included in the result. 
 
Results 
Data from 12795 women who underwent urodynamics for various lower 
urinary tract symptoms during the study period (January 2000 to December 
2010) were reviewed. 1838 women (study group) aged over 17 18 years 
complained of secondary nocturnal enuresis in this study, with a prevalence 
rate of 14.4%. The demographic details of all the patients in the study are 
summarized in table 1. The average age of women in the study group was 
52.6 years (compared to 52.5 in the control group), which was not significant 
(p= 0.961). The mean parity of women with SNE was 2.4, which was the 
same in the control group and[DGE2] this was not significant (p= 0.158). High 
BMI (> 30) was significantly associated with SNE in women (27.4% Vs. 
19.4%; OR= 1.47, p< 0.0001).  Significant proportion of women with SNE also 
smoked cigarettes (30.1% Vs. 15.9%; OR= 2.03, p< 0.001) and reported 
using anti-depressant medications (16.3% Vs. 8.5%; OR= 1.795, p< 0.001). 
Neurological conditions like cerebro-vascular accidents and multiple sclerosis 
were significantly higher in women with SNE (10.3% Vs. 5.2%; OR= 2.12, p< 
0.001). Previous hysterectomy was also significantly associated with SNE 
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(36% Vs. 30.3%; OR= 1.19, p= 0.032). Menopausal status was not 
significantly associated with SNE (p=0.638).  
 
Important LUTS and urodynamic findings are summarized in table 2. The 
mean daytime frequency in women with SNE was 8.3 (SD= 3.4), which was 
slightly higher compared to 7.95 in the control group (OR= 0.97, p= 0.03). The 
mean nocturia episode was 1.76 (SD = 2.8) in women with SNE compared to 
1.26 in the control group, which was statistically highly significant (OR= 1.38, 
p < 0.001). Significant proportion of women with SNE reported overactive 
bladder (OAB) symptoms (82.6% Vs. 62.6%; OR= 1.65, p< 0.001). Stress 
incontinence was not a significant symptom reported at history taking (p= 
0.264).  
 
At uroflowmetry, a significant proportion of women with SNE (8.1% Vs. 7.1%) 
had significant post-void residual volume of urine of > 150 ml, (OR = 1.6, p< 
0.001). The mean residual volume of urine retained, in women with significant 
PVR (> 150 ml) was 325.8 ml compared to 269.1 ml in the control group, 
which was significant (p= 0.001). The average flow rate was slightly lesser in 
the SNE group (21.1 ml/s Vs. 21.9 ml/s, p= 0.017). Women with SNE had a 
significantly lower cystometric capacity (219.2 ml Vs. 344.5 ml, p < 0.001).  
 
41.1% of women with SNE had low maximum urethral closure pressures 
compared to 37.9% in the control group, which was statistically significant 
(OR= 1.34, p< 0.001). Detrusor overactivity was seen in 55.8% of the study 
group (compared to 40.3% in the control) but this was not statistically 
significant (p= 0.231). Detrusor overactivity incontinence was demonstrable in 
22.9% of women in the study group (22.9% Vs. 12.4%; OR= 1.75, p< 0.001), 
which was statistically highly significant. Neither a symptom of SUI (p= 0.264) 
nor a urodynamic finding of UDSI (p= 0.454) were significantly associated 
with SNE. A combination of UDSI with DOI (mixed UI) was highly significant 
(37.3% Vs. 21.5%; OR= 1.64, p < 0.001).  
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Discussion 
SNE is a common condition reported by adult women presenting with 
bothersome LUTS. SNE is significantly associated with overactive bladder 
symptoms and urinary incontinence. High BMI, cigarette smoking, anti-
depressant usage were the most significant risk factors associated with SNE. 
Neurological conditions and pervious hysterectomy were also significantly 
associated with SNE. Detrusor overactivity incontinence and a low MUCP 
were the most common associated urodynamic findings.  
 
A prevalence of 14.4% of SNE in women presenting with bothersome LUTS 
for urodynamic testing suggests a high prevalence of this poorly studied 
condition. Epidemiological studies in adult population quote a prevalence rate 
of around 3% in adult population (Moilanen et al. 1998; Forsythe & Redmond 
1974). A large epidemiological survey suggested an overall prevalence of 
SNE at 0.5% in non-institutionalized adults (18 – 64 years) (Hirasing et al. 
2009). A study based on a database review of 3000 patients of adult onset 
nocturnal enuresis without daytime incontinence quoted a prevalence rate of 
0.02% (Schäfer et al. 2002). Our study was based on a large database of 
adult women who presented with various lower urinary tract symptoms 
indicating a higher prevalence of SNE in adult women with LUTS. It is an 
indication of the polysymptomatic nature of the problem. It may also be an 
indication of how women respond to other LUTS in association with SNE, 
which also reflects their healthcare seeking behavior.  
 
Majority of patients in our study complained of overactive bladder symptoms 
(OR= 1.65) [DGE3]and nocturia (OR= 1.38) [DGE4]was a significant association 
with SNE. SNE is a nighttime problem; it is possible that women get up more 
often to ensure that they empty their bladder to avoid SNE episodes. 
Nocturnal polyuria and abnormal diurnal rhythm of plasma vasopressin are 
suggested as possible mechanisms for NE (Kamperis et al. 2006; Rittig et al. 
1989), which could explain this finding. The database however, did not 
provide data on nighttime voided volumes and hence we were unable to 
analyze this data further. DO was more prevalent with SNE but this was not 
statistically significant. DOI (OR= 2.16) was the most significant urodynamic 
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findings demonstrated in women with SNE, which suggests a dysfunction of 
the bladder detrusor as an important mechanism in the pathophysiology of 
SNE. Detrusor overactivity has been reported in other studies as one of the 
predominant urodynamic finding and an important factor in the 
pathophysiology of NE (Wadie 2004; Foldspang & Mommsen 1994). A 
genetic inheritance of SNE with associated DO has also been proposed 
(Chiozza et al. 1998). Current evidence is conflicting on the role of reduced 
bladder capacity in the pathophysiology of nocturnal enuresis (Ciftci et al. 
2012; Kamperis et al. 2006; Lin et al. 2004). The mean maximum cystometric 
capacity was slightly lower in women with SNE in our study (mean difference 
of 53.3, p< 0.001), which does indicate a lower bladder capacity as a possible 
factor in the pathogenesis of NE.  A low MUCP was an independent risk factor 
associated with SNE and was significantly low in the study group, also 
suggesting a possible role in the etiopathogenesis of SNE. High urethral 
closure pressure suggestive of obstruction was not noted in our cases, which 
is in contrast to some studies suggesting retention with outflow obstruction (C 
K Yeung et al. 2004).  A smaller bladder with detrusor dysfunction and a low 
MUCP may suggest a possible mechanism of adult bed-wetting. A significant 
proportion of women with SNE did not complain of stress incontinence, and 
UDSI was not a significant association noted, which indicates that stress 
incontinence is unlikely to have a role in SNE.  
 
Cigarette smoking is associated with overactive bladder symptoms and 
detrusor overactivity (Tampakoudis et al. 1995; Dallosso et al. 2003). 
Smoking was a significant finding associated with SNE in our study (OR= 
2.26). Nicotine, a nicotinic acetylcholine receptors (nAChRs) agonist, has a 
role in the modulation of neurotransmitter release in both the central and 
peripheral nervous systems resulting in detrusor contractile responses 
(Masuda et al. 2006). It is however difficult to establish a causal role of 
smoking based on this study. Obesity is a known risk factor for both stress 
and UUI[DGE5] (Mayo & Burns 1990; Whiteside & Arnold 1975; Chung Kwong 
Yeung et al. 2002). Even though the mechanism is not fully understood on its 
role in UUI, obesity may cause chronic strain, stretching and weakening the 
muscles, nerves and other pelvic floor structures (Subak et al. 2009). Obesity 
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may also have an affect on the nerve conduction velocities, affecting neuronal 
control of the urinary bladder and contribute to DOI and in turn SNE (Miscio et 
al. 2005). Some of these mechanisms explain the significant association of a 
high BMI with SNE in the study group.  
 
Even though we have not used any objective tools to measure depression, 
16.3% of our patients reported using antidepressants (OR= 2.1, p<0.001). 
This data could be an indication of a higher association of depression with 
nocturnal enuresis or may indicate a higher antidepressant usage in women 
with SNE. It is difficult to establish a causal relationship based on the data 
from our study. It is known that NE is associated with depression and low self-
esteem in adults (Chung Kwong Yeung et al. 2004). NE might be associated 
with hypnotic medications (Vural et al. 2007). Antidepressants may also 
interfere with arousal mechanisms at night, which may lead to nocturnal 
enuresis (Neveus 2003). Disorders of sleep and arousal have been implicated 
in the pathophysiology of NE (Umlauf & Chasens 2003; Wolfish 2001). No 
information could be drawn from the database to evaluate arousal and sleep 
to explain this finding further. However, the association of antidepressant with 
SNE indicates a possible neurological basis for the occurrence SNE. 
 
The integrity of the central nervous system, nervous control of the bladder and 
the arousal system of the central nervous system are crucial for maintenance 
of nighttime bladder function (Fowler et al. 2008). A tenth of all our cases with 
nocturnal enuresis developed secondary nocturnal enuresis in association 
with a neurological pathology, which indicates a disruption in the neuronal 
pathways controlling the bladder. Damage to the neuronal circuits either at the 
brain or spinal cord results in unmasking of primitive voiding reflexes and 
trigger detrusor overactivity and incontinence (de Groat 1997). This may also 
explain the higher incidence of detrusor overactivity in these cases and 
explain the associated SNE.  
 
This study is an evaluation of urodynamic findings of individuals complaining 
of SNE with or without other lower urinary tract symptoms. SNE alone was not 
the primary focus of the urodynamic testing in many of the cases, but was 
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routinely questioned at history taking. Cystometric tests were done in all 
cases as per ICS recommendations, which provide valuable data for 
interpretation and understanding of SNE. All the patients in the study were 
awake and the test results are an indirect reflection of a problem, which 
occurs at sleep. Urodynamic assessments were conducted at daytime when 
the subjects were awake and hence the findings must be interpreted as only 
associations. Treatment received and outcomes of treatment were also not 
available from the database and it is also not helped by the fact that some of 
the cases were referred from other centres for urodynamic testing only. These 
factors do limit further correlation of the urodynamic findings to patient 
symptoms and outcomes of treatment. Further long-term longitudinal studies 
exploring OAB symptoms and NE are needed to understand symptoms 
emergence and etiopathogenesis of SNE. 
 
Conclusion 
Patients with adult SNE usually present with OAB symptoms. High BMI, 
cigarette smoking, antidepressant use and neurological conditions are 
significant risk factors associated with SNE. A low bladder capacity, detrusor 
overactivity incontinence and Low MUCP are the most significant urodynamic 
findings associated with SNE. Further studies are needed to evaluate the 
importance of these findings on treatment outcomes of patients with NE.  
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Abbreviations used: 
 
NE  Nocturnal enuresis 
SNE  Adult onset secondary nocturnal enuresis 
DO  Detrusor overactivity 
UDSI  Urodynamic stress incontinence 
UPP  Urethral pressure profile 
OAB  Overactive bladder 
BMI  Body mass index 
NAD  Nothing abnormal detected 
ICS  International continence society 
PVR  Post-void residual volume of urine 
MUCP Maximum urethral closure pressure 
UUI  ? 
 
 
Table 1: 
Demographic details of women LUTS, with and without secondary NE 
 
Parameter SNE group 
n1 (%) 
Control group  
n2 (%) 
p-value Odds ratio  95% Confidence interval 
Number 1838 (14.4) 10957 (85.6)    
High BMI (>30) 504 (27.4) 2122 (19.4) <0.0001 1.47 1.27 – 1.71 
Smokers 554 (30.1) 1744 (15.9) <0.0001 2.033 1.73 – 2.39 
Anti-depressants 300 (16.3) 935 (8.5) <0.0001 1.795 1.45 – 2.22 
Neurological conditions 190 (10.3) 565 (5.2) <0.0001 2.12 1.78 - 2.52 
Menopausal 1157 (62.9) 6685 (61) 0.638 0.948 0.76 – 1.18 
Previous hysterectomy 662 (36) 3325 (30.3) 0.032 1.190 1.02 – 1.39 
 Mean (SD) Mean (SD)    
Mean age 52.6 (14.9) 52.5 (13.24) 0.961 0.989 0.99 – 0.99 
Parity 2.4 (1.5) 2.4 (1.3) 0.158 0.961 0.91 – 0.99 
 
Table 2: 
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Lower Urinary tract symptoms and urodynamic findings in women, with 
and without secondary NE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter 
SNE group 
n1 (%) 
Control group 
n2 (%) 
P-value Odds ratio 95% confidence 
interval 
Overactive Bladder (OAB) symptoms 1518 (82.6) 6863 (62.6) <0.0001 1.65 1.4 -1.95 
Stress urinary incontinence  1510 (82.2) 9130 (83.3) 0.264 1.13 0.92 – 1.39 
Low MUCP 756 (41.1) 4158 (37.9) <0.001 1.34 1.14 – 1.58 
Detrusor overactivity 1027 (55.8) 4415 (40.3) 0.231 1.16 0.91 – 1.49 
Detrusor Overactivity incontinence (DOI) 420 (22.9) 1321 (12.4) <0.0001 1.75 1.39 – 2.21 
UDSI 818 (44.5) 5513 (50.3) 0.454 0.910 0.71 – 1.16 
DOI + UDSI (Mixed UI) 685 (37.3) 2357 (21.5) <0.0001 1.64 1.3 – 2.08 
 Mean (SD) Mean (SD)    
Daytime Frequency  8.3 (3.35) 7.95 (2.79) 0.031 0.97 0.95 – 0.99 
Nocturia Episodes 1.76 (1.34) 1.26 (1.17) <0.001 1.38 1.3 – 1.46 
